Abstract: Various embodiments of the present application are directed to a method for forming a boundary structure separating a memory cell and a logic device. In some embodiments, an isolation structure is formed separating a memory semiconductor region from a logic semiconductor region. A memory cell structure is formed on the memory semiconductor region, and a memory capping layer is formed covering the memory cell structure and the logic semiconductor region. A first etch is performed into the memory capping layer to remove the memory capping layer from the logic semiconductor region, and to define a slanted, logic-facing sidewall on the isolation structure. A logic device structure is formed on the logic semiconductor region. Further, a second etch is performed into the memory capping layer to remove the memory capping layer from the memory semiconductor, while leaving a dummy segment of the memory capping layer that defines the logic-facing sidewall.

Abstract: The present invention relates to a nucleic acid complex pair for detecting a target nucleic acid in a sample, and more particularly to a nucleic acid complex pair used for detecting a target DNA in a sample, wherein the nucleic acid complex pair includes a first nucleic acid complex including a first determination region, a first pairing region, and a first detection region; and a second nucleic acid complex including a second determination region, a second paring region, and a second detection region, wherein the first determination region includes at least a partial domain that complementarily binds to a first target nucleic acid sequence, and the second determination region includes at least a partial domain that complementarily binds to a second target nucleic acid sequence, wherein the first pairing region and the second pairing region a domain where they can complementarily hybridize to each other.

Abstract: Embodiments of the present invention provide a lateral flow assay method and strip wherein a sample is injected into a sample pad, a preconcentration kit is coupled to the sample pad to preconcentrate analytes, and a conjugate pad or a test pad is connected to the sample pad to transfer the analytes to the conjugate pad or the test pad, whereby a biomarker present at a low concentration can be detected.

Abstract: Disclosed herein are an intrusion response apparatus and method for a vehicle network. The intrusion response method for a vehicle network is performed by an intrusion response apparatus for the vehicle network, and includes receiving attack detection information about an intrusive attack on the vehicle network from an intrusion detection system, selecting at least one target electronic control unit that is to be instructed to respond to the intrusive attack from among multiple electronic control units, and sending a response instruction message to the at least one target electronic control unit so that the target electronic control unit responds to the intrusive attack.

Abstract: A method for operating a plurality of carriers by a first base station in a wireless communication system supporting a primary carrier and at least one secondary carrier is discussed. The method includes transmitting, to a user equipment through the primary carrier, control information for exchanging traffic via the at least one secondary carrier with the user equipment; transmitting, to the user equipment, the traffic through the secondary carrier, wherein the user equipment is configured to receive the traffic based on the control information; and transmitting, to the user equipment, a message for a procedure of an entrance to a second base station. Further, the primary carrier is changed on the procedure of the entrance based on the message.

Abstract: The present invention relates to a mutated tau protein fragment and a use thereof. The mutated tau protein fragment of the present invention consists of 12 amino acids and thus can easily be prepared. In addition, when the mutated tau protein fragment is injected into an individual as an antigen, a neutralizing antibody against the mutated tau protein is generated. Moreover, the mutated tau protein fragment reduces the aggregation of abnormal tau proteins. Accordingly, the mutated tau protein fragment of the present invention can be effectively used for the prevention or treatment of degenerative neurological diseases.

Abstract: Provided is a packaging container for preventing sealing of packaging containers such that a continuous operation, such as an automatic insertion operation, etc., is able to be smoothly performed in a sequential product packaging process, with easy separation of packaging containers that are vertically stacked.

Abstract: Provided is a display device, comprising a display panel which comprises a first area and a second area located around the first area; and an under-panel sheet which is located under the display panel and overlaps the first area and the second area, wherein the under-panel sheet comprises a buffer member and a strength reinforcing member, wherein the strength reinforcing member is thinner than the buffer member, and a ratio of a thickness of the buffer member to a thickness of the strength reinforcing member is 3 to 6 times.

Abstract: Methods for fabricating a transistor and an electro-static discharge (ESD) device are provided. In a method, a first well area doped with a first well ion is formed in a base substrate. A second well area is doped with a second well ion in the base substrate. The second well area includes a first region adjacent to the first well area. A first ion doping region doped with first ions is formed in the first well area and the first region. A type of the first ions is the same as a type of the first well ion and opposite to a type of the second well ion. A gate structure is formed on a part of the first well area and at least a part of the first region.

Abstract: A home appliance has an improved structure to provide anti-fingerprinting properties and a method of manufacturing the same. The home appliance includes a main body including an internal space, a door provided to open and close the internal space, and a coating layer formed on at least one of the main body and the door, wherein the coating layer includes a first layer provided to cover a surface of at least one of the main body and the door and including silicon oxide, and a second layer provided to cover the first layer using an ultraviolet curing paint including a silane coupling agent.

Abstract: The present disclosure provides a method and system for creating decentralized repository of fraud IP and publishers using block chain. The block chain network creates a central repository for decentralized shared ledger. The block chain network adds a ledger in decentralized shared ledger for each interaction on an application. In addition, the block chain network authorizes at least one of a plurality of stakeholders to access the decentralized shared ledger after receiving a request from at least one of the plurality of stakeholders. Further, the block chain network analyzes the interaction and past data received from a plurality of stake holders. Furthermore, the block chain network blocks device IPs, device Id's, device type and the publishers mentioned in blacklist of the decentralized shared ledger.

Abstract: A medication dispenser includes a base seat, a circuitry unit and an outer casing. The base seat includes a mouthpiece. The circuitry unit includes a first circuit board, a battery, and first and second switches disposed on the first circuit board. The outer casing is movable relative to the base seat between a close position where the outer casing covers the mouthpiece and where the first switch is actuated such that electric power is prevented from being supplied from the battery to the first circuit board, and an open position where the outer casing uncovers the mouthpiece and where the second switch is actuated such that electric power is supplied from the battery to the first circuit board.

Abstract: The present invention provides a chelating agent for reservoir acidification and stimulating injection and its preparation method and application. The raw material composition of the chelating agent comprises: 10.0%-20.0% of methanesulfonic acid, 10.0%-20.0% of methanol, 10.0%-20.0% of polyaspartic acid, 10.0%-15.0% of epoxy succinic acid, 5.0%-10.0% of sodium cetyl sulfonate, 10.0%-15.0% of cetyltrimethylammonium bromide and the balance of water. The present invention also provides a preparation method of the above chelating agent. The chelating agent for reservoir acidification and stimulating injection of the invention is used in an acidizing and stimulating injection process, wherein it can effectively dissolve rock cracks, be used directly without need to be reversed.

Abstract: A method and implantable medical device system for delivering a cardiac pacing therapy that includes suspending delivery of the LV cardiac pacing therapy and sensing far-field cardiac signals via one or more far-field sensing vectors formed between a plurality of electrodes positioned on a single-pass coronary sinus lead. Far-field signal features are determined in response to the sensed far-field cardiac signals, a first offset interval and a second offset interval are determined in response to the determined far-field signal features, and an AV delay of the LV cardiac pacing therapy is adjusted in response to the determined first offset interval and second offset interval. Delivery of the LV cardiac pacing therapy having the adjusted AV delay is subsequently resumed.

Abstract: A synthetic image display device includes: a beam projector configured to project a first image; a screen on which the first image projected from the beam projector is formed; and a transparent display panel disposed so as to face the screen and configured to display a second image to be combined and viewed with the first image formed on the screen, the transparent display panel being formed with a pinhole for penetration of light in each pixel so that the first image penetrates and is viewed through the transparent display panel.

Abstract: The present invention provides a high voltage battery rack, including: a plurality of battery modules electrically connected with each other; and a rack controller configured to control the plurality of battery modules, wherein each of the plurality of battery modules comprises: external terminals; and an MSD module configured to determine whether a voltage is applied to the external terminals during operation.

Abstract: A technical concept of the present disclosure provides a method of producing a semiconductor package, the method including operations of: arranging a plurality of wafers on a tray, forming an interconnect structure on the tray and the plurality of wafers, and separating the plurality of wafers from the tray.

Abstract: A memory device may include multiple channel regions extending in a direction perpendicular to an upper surface of a substrate, a plurality of gate electrode layers and a plurality of insulating layers stacked on the substrate to be adjacent at least a portion of the plurality of channel regions, an interlayer insulating layer disposed on the plurality of gate electrode layers, a plurality of cell contact plugs passing through the interlayer insulating layer. Each of the plurality of cell contacts is connected to each of the plurality of gate electrode layers. A vertical insulating layer extends from the interlayer insulating layer disposed between the plurality of channel regions and the plurality of cell contact plugs and has a portion surrounded by at least one of the plurality of gate electrode layers.

Abstract: A coil component includes: a body including a support member including a through-hole and a via hole spaced apart from the through-hole, an internal coil supported by the support member and including a plurality of conductive units wound in one direction, and an encapsulant encapsulating the support member and the internal coil and filling the through-hole; and an external electrode disposed on an external surface of the body and connected to the internal coil.

Abstract: The invention provides compounds that inhibit monocarboxylate transporters, such as MCT1 and MCT4. Compounds of the invention can be used for treatment of a condition in a patient, wherein the condition is characterized by the heightened activity or by the high prevalence of MCT1 and/or MCT4, such as cancer or type II diabetes.